| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972946 | The Journal of Heart and Lung Transplantation | 2006 | 8 Pages |
Abstract
TM is achievable in the majority of cardiac transplant recipients. Patients who tolerated reduced immunosuppression enjoyed greater survival than those treated with other regimens, without additional high-grade rejection or vasculopathy. These promising results remain to be confirmed in a prospective trial.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Steven A. MD, David A. MD, Mamata M. MD, Sean MD, Sarah MD, Ming RN, Mary C. RN, Steven L. MD, PhD, David MD, Alan L. MD,